Surfactant-secreted phospholipase A

Bronchoalveolar Lavage Fluid Epithelial Cells / metabolism Female Humans Infant, Newborn Infant, Premature / physiology Male Phospholipases A2, Secretory / antagonists & inhibitors Phospholipids Pulmonary Surfactants / metabolism Respiration
RDS lung injury newborn infant phospholipase A2 prematurity surfactant

Journal

American journal of physiology. Lung cellular and molecular physiology
ISSN: 1522-1504
Titre abrégé: Am J Physiol Lung Cell Mol Physiol
Pays: United States
ID NLM: 100901229

Informations de publication

Date de publication:
01 07 2020
Historique:
pubmed: 14 5 2020
medline: 7 10 2020
entrez: 14 5 2020
Statut: ppublish

Résumé

Secreted phospholipase A

Identifiants

DOI: 10.1152/ajplung.00462.2019 PMID: 32401671
pubmed: 32401671
doi: 10.1152/ajplung.00462.2019
doi:

Substances chimiques

Phospholipids 0
Pulmonary Surfactants 0
Phospholipases A2, Secretory EC 3.1.1.4

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

L95-L104

Auteurs

Daniele De Luca (D)

Division of Pediatrics and Neonatal Critical Care, "A.Béclère" Medical Center, South Paris University Hospitals, Assistance Publique - Hôpitaux de Paris (APHP), Paris, France.
Physiopathology and Therapeutic Innovation Unit-INSERM U999, South Paris-Saclay University, Paris, France.
Cystic fibrosis and Bronchial diseases team-INSERM U938, Institut Pasteur, Paris, France.
ORCID: 0000-0002-3846-4834

Shivani Shankar-Aguilera (S)

Division of Pediatrics and Neonatal Critical Care, "A.Béclère" Medical Center, South Paris University Hospitals, Assistance Publique - Hôpitaux de Paris (APHP), Paris, France.
Cystic fibrosis and Bronchial diseases team-INSERM U938, Institut Pasteur, Paris, France.

Chiara Autilio (C)

Department of Biochemistry and Molecular Biology, Faculty of Biology, and Research Institut-Hospital "12 de Octubre," Complutense University, Madrid, Spain.

Roberto Raschetti (R)

Division of Pediatrics and Neonatal Critical Care, "A.Béclère" Medical Center, South Paris University Hospitals, Assistance Publique - Hôpitaux de Paris (APHP), Paris, France.

Luca Vedovelli (L)

PCare Laboratory, Fondazione Istituto di Ricerca Pediatrica "Città della Speranza," Padua, Italy.

Catherine Fitting (C)

Cytokines and Inflammation Unit, Institut Pasteur, Paris, France.

Christine Payré (C)

Université Côte d'Azur, Centre National de la Recherche Scientifique, Institut de Pharmacologie Moléculaire et Cellulaire, UMR7275, Valbonne Sophia Antipolis, France.

Louise Jeammet (L)

Université Côte d'Azur, Centre National de la Recherche Scientifique, Institut de Pharmacologie Moléculaire et Cellulaire, UMR7275, Valbonne Sophia Antipolis, France.

Jesus Perez-Gil (J)

Department of Biochemistry and Molecular Biology, Faculty of Biology, and Research Institut-Hospital "12 de Octubre," Complutense University, Madrid, Spain.

Paola E Cogo (PE)

PCare Laboratory, Fondazione Istituto di Ricerca Pediatrica "Città della Speranza," Padua, Italy.
Division of Pediatrics, Department of Medicine and Surgery, University of Udine, Udine, Italy.

Virgilio P Carnielli (VP)

PCare Laboratory, Fondazione Istituto di Ricerca Pediatrica "Città della Speranza," Padua, Italy.
Division of Neonatology, "G. Salesi" Women's and Children Hospital, Polytechnical University of Marche, Ancona, Italy.

Gérard Lambeau (G)

Université Côte d'Azur, Centre National de la Recherche Scientifique, Institut de Pharmacologie Moléculaire et Cellulaire, UMR7275, Valbonne Sophia Antipolis, France.

Lhousseine Touqui (L)

Cystic fibrosis and Bronchial diseases team-INSERM U938, Institut Pasteur, Paris, France.
Sorbonne Université, INSERM UMR_S 938, Centre de Recherche Saint-Antoine (CRSA), Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Techniques d'investigation › Irrigation thérapeutique › Lavage bronchoalvéolaire › Liquide de lavage bronchoalvéolaire › Surfactant-secreted phospholipase A
questionsmedicales.fr › Cellules › Cellules épithéliales › Surfactant-secreted phospholipase A
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Surfactant-secreted phospholipase A
questionsmedicales.fr › Personnes › Tranches d'âge › Nourrisson › Nouveau-né › Surfactant-secreted phospholipase A
questionsmedicales.fr › Personnes › Tranches d'âge › Nourrisson › Nouveau-né › Prématuré › Surfactant-secreted phospholipase A
questionsmedicales.fr › Enzymes et coenzymes › Enzymes › Hydrolases › Esterases › Carboxylic ester hydrolases › Phospholipases A › Phospholipases A2 › Secretory Phospholipases A2 › Surfactant-secreted phospholipase A
questionsmedicales.fr › Lipides › Lipides membranaires › Phospholipides › Surfactant-secreted phospholipase A
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Agents de l'appareil respiratoire › Surfactants pulmonaires › Surfactant-secreted phospholipase A
questionsmedicales.fr › Phénomènes physiologiques respiratoires et circulatoires › Phénomènes physiologiques respiratoires › Respiration › Surfactant-secreted phospholipase A